Telos Capital Management Inc. Grows Holdings in Danaher Co. (NYSE:DHR)

Telos Capital Management Inc. lifted its stake in Danaher Co. (NYSE:DHR) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,031 shares of the conglomerate’s stock after purchasing an additional 220 shares during the period. Danaher comprises about 1.1% of Telos Capital Management Inc.’s investment portfolio, making the stock its 28th largest position. Telos Capital Management Inc.’s holdings in Danaher were worth $10,337,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in the stock. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America bought a new position in Danaher during the 3rd quarter worth about $39,000. MidAtlantic Capital Management Inc. bought a new stake in shares of Danaher in the 3rd quarter valued at about $40,000. Finally, FSA Wealth Management LLC purchased a new stake in shares of Danaher in the 3rd quarter worth approximately $50,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a report on Thursday, October 31st. Citigroup dropped their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 30th. Wells Fargo & Company reduced their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. JPMorgan Chase & Co. lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Barclays reduced their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $209.95 on Friday. The stock has a market cap of $151.64 billion, a price-to-earnings ratio of 39.76, a PEG ratio of 2.80 and a beta of 0.83. Danaher Co. has a 12 month low of $209.10 and a 12 month high of $281.70. The company has a 50 day simple moving average of $233.96 and a two-hundred day simple moving average of $252.39. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the business earned $2.09 EPS. As a group, analysts predict that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.